Chronic Lymphocytic Leukemia (CLL) Latest Advances

Case Report and Retrospective Review of Acanthamoeba Encephalitis and Chronic Lymphocytic Leukemia, United States.

Journal: Emerging infectious diseases

Published: August 28, 2026

Refined Continuous Risk Index for Accurately Predicting Outcomes of Patients With Chronic Lymphocytic Leukemia After Limited-Duration Therapy.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: August 27, 2026

Genetic control of local mutation rates.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: August 27, 2026

Correction: Have Fixed-Duration (FD) Regimens Delivered on Their Promise in Chronic Lymphocytic Leukemia and What Is the Future of FD Regimens? A Narrative Review.

Journal: Advances in therapy

Published: August 24, 2026

Clonally Related Chronic Lymphocytic Leukemia and Malignant Histiocytic Neoplasm (Histiocytic Sarcoma With Overlapping Langerhans Cell Phenotype): Divergent Evolution From a Shared Cell-Of-Origin.

Journal: American journal of hematology

Published: August 24, 2026

Zanubrutinib versus fludarabine, cyclophosphamide and rituximab in fit, treatment-naïve patients with chronic lymphocytic leukemia: a matching-adjusted indirect comparison.

Journal: Journal of comparative effectiveness research

Published: August 21, 2026

α2,3-sialylation on human naïve T cells restrains bispecific engager-mediated anti-tumor immunity.

Journal: bioRxiv : the preprint server for biology

Published: August 20, 2026

Sequencing asymmetry: the case for caution before first-line pirtobrutinib in chronic lymphocytic leukemia.

Journal: Annals of hematology

Published: August 20, 2026

Individualised but Specific Exercise Training Improves Physiologic Reserve and Reduces Frailty in Older Adults with Chronic Lymphocytic Leukaemia: A 12-Week Pragmatic Randomised Controlled Trial.

Journal: medRxiv : the preprint server for health sciences

Published: August 20, 2026

Bilateral optic neuropathy secondary to chronic lymphocytic leukaemia infiltration.

Journal: BMJ case reports

Published: August 20, 2026

Mapping the Global Clinical Trial Landscape of Chimeric Antigen Receptor T-Cell Therapy for Chronic Lymphocytic Leukemia: Current Status and Future Perspectives.

Journal: American journal of therapeutics

Published: August 19, 2026

Central nervous system involvement of chronic lymphocytic leukaemia with brain and spinal cord infiltration.

Journal: BMJ case reports

Published: August 18, 2026

Chronic Lymphocytic Leukemia (CLL) Latest Advances

Find the Latest Research About Chronic Lymphocytic Leukemia (CLL)

Case Report and Retrospective Review of Acanthamoeba Encephalitis and Chronic Lymphocytic Leukemia, United States.

Case Report and Retrospective Review of Acanthamoeba Encephalitis and Chronic Lymphocytic Leukemia, United States.

Refined Continuous Risk Index for Accurately Predicting Outcomes of Patients With Chronic Lymphocytic Leukemia After Limited-Duration Therapy.

Refined Continuous Risk Index for Accurately Predicting Outcomes of Patients With Chronic Lymphocytic Leukemia After Limited-Duration Therapy.

Genetic control of local mutation rates.

Genetic control of local mutation rates.

Correction: Have Fixed-Duration (FD) Regimens Delivered on Their Promise in Chronic Lymphocytic Leukemia and What Is the Future of FD Regimens? A Narrative Review.

Correction: Have Fixed-Duration (FD) Regimens Delivered on Their Promise in Chronic Lymphocytic Leukemia and What Is the Future of FD Regimens? A Narrative Review.

Clonally Related Chronic Lymphocytic Leukemia and Malignant Histiocytic Neoplasm (Histiocytic Sarcoma With Overlapping Langerhans Cell Phenotype): Divergent Evolution From a Shared Cell-Of-Origin.

Clonally Related Chronic Lymphocytic Leukemia and Malignant Histiocytic Neoplasm (Histiocytic Sarcoma With Overlapping Langerhans Cell Phenotype): Divergent Evolution From a Shared Cell-Of-Origin.

Zanubrutinib versus fludarabine, cyclophosphamide and rituximab in fit, treatment-naïve patients with chronic lymphocytic leukemia: a matching-adjusted indirect comparison.

Zanubrutinib versus fludarabine, cyclophosphamide and rituximab in fit, treatment-naïve patients with chronic lymphocytic leukemia: a matching-adjusted indirect comparison.

α2,3-sialylation on human naïve T cells restrains bispecific engager-mediated anti-tumor immunity.

α2,3-sialylation on human naïve T cells restrains bispecific engager-mediated anti-tumor immunity.

Sequencing asymmetry: the case for caution before first-line pirtobrutinib in chronic lymphocytic leukemia.

Sequencing asymmetry: the case for caution before first-line pirtobrutinib in chronic lymphocytic leukemia.

Individualised but Specific Exercise Training Improves Physiologic Reserve and Reduces Frailty in Older Adults with Chronic Lymphocytic Leukaemia: A 12-Week Pragmatic Randomised Controlled Trial.

Individualised but Specific Exercise Training Improves Physiologic Reserve and Reduces Frailty in Older Adults with Chronic Lymphocytic Leukaemia: A 12-Week Pragmatic Randomised Controlled Trial.

Bilateral optic neuropathy secondary to chronic lymphocytic leukaemia infiltration.

Bilateral optic neuropathy secondary to chronic lymphocytic leukaemia infiltration.

Mapping the Global Clinical Trial Landscape of Chimeric Antigen Receptor T-Cell Therapy for Chronic Lymphocytic Leukemia: Current Status and Future Perspectives.

Mapping the Global Clinical Trial Landscape of Chimeric Antigen Receptor T-Cell Therapy for Chronic Lymphocytic Leukemia: Current Status and Future Perspectives.

Central nervous system involvement of chronic lymphocytic leukaemia with brain and spinal cord infiltration.

Central nervous system involvement of chronic lymphocytic leukaemia with brain and spinal cord infiltration.